Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Mukerjee, Sonjoya | McKnight, Michael E.a | Nasoff, Marca | Glassy, Mark C.b; *
Affiliations: [a] Novopharm Biotech, Inc., 6190 Cornerstone Court East, Suite 106, San Diego, CA 92121, USA | [b] The Rajko Medenica Research Foundation, 10246 Parkdale Ave., San Diego, CA 92126, USA
Correspondence: [*] Corresponding author.
Abstract: Cocktails of human monoclonal antibodies (HuMAbs) have been used to increase the likelihood of identifying heterogeneous cancer cells. We utilized 3 HuMAbs termed SK-1, GM4, and GMA1, which recognized a 42–46kDa two chain structure, a 57kDa antigen, and the ganglioside GD3, respectively. An estimated two dozen cell lines were tested for the coexpression of these antigens and this was found to be present only on pancreatic carcinoma cell line, PANC-1; A 24 hr treatment of PANC-1 cells with interferon gamma (IFNγ; 100 units), interferon beta (IFNβ; 1000 units), as well as interferon alpha (IFNα; 1000 units) resulted in roughly a four fold increase in the co-expression of the 42–46 kDa/GD3 antigens as well as the 42–46 kDa/ 57 kDa antigens. After a 4 day incubation the co-expression of these antigens progressed and IFN α treatment had the most pronounced effect, which was 8 fold higher than background for the 42–46kDa/57kDa antigens, whereas IFN β resulted in a five fold antigen upregulation. The pronounced effect of vinblastine on the co-expression of the 42–46 kDa/GD3 antigens (4 fold on day 1 and , 10 fold on day 4) and 42–46 kDa/57kDa antigens on PANC-1 (5 fold on day 1 and 7 fold over background on day 4) cells can be seen at concentrations as low as 10-7M. Colchicine and vincristine dramatically enhanced co-expression of these tumor antigens on day 4 but not on day 1 PANC-1cells. The expression of these antigens was also found to be cell cycle dependent.
Keywords: antigen, co-expression, human antibody vinca alkaloids, interferon
DOI: 10.3233/HAB-1999-9102
Journal: Human Antibodies, vol. 9, no. 1, pp. 9-22, 1999
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl